Cartesian Therapeutics, Inc.
RNAC
$10.50
-$0.07-0.66%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 212.61M | 219.20M | 87.23M | 103.42M | 76.91M |
| Total Receivables | 872.00K | 5.81M | 35.51M | 4.38M | 8.85M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.14M | 4.13M | 2.04M | 3.02M | 4.97M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | 300.00K | -- |
| Total Current Assets | 216.63M | 229.14M | 124.78M | 111.11M | 90.73M |
|
|
|||||
| Total Current Assets | 216.63M | 229.14M | 124.78M | 111.11M | 90.73M |
| Net Property, Plant & Equipment | 15.45M | 23.75M | 20.52M | 11.96M | 12.18M |
| Long-term Investments | 48.16M | 48.16M | 48.16M | 48.16M | 48.16M |
| Goodwill | 48.16M | 48.16M | 48.16M | 48.16M | 48.16M |
| Total Other Intangibles | 150.60M | 150.60M | 150.60M | 150.60M | 150.60M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.19M | 1.67M | 1.67M | 1.38M | 1.38M |
| Total Assets | 435.02M | 455.32M | 347.74M | 325.21M | 305.05M |
|
|
|||||
| Total Accounts Payable | 288.00K | 517.00K | 2.86M | 2.52M | 3.15M |
| Total Accrued Expenses | 11.29M | 9.02M | 7.74M | 8.93M | 14.61M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.85M | 2.77M | 2.52M | 2.23M | 2.17M |
| Total Finance Division Other Current Liabilities | 8.54M | 9.09M | 12.99M | 22.98M | 48.29M |
| Total Other Current Liabilities | 8.54M | 9.09M | 12.99M | 22.98M | 48.29M |
| Total Current Liabilities | 22.98M | 21.41M | 26.12M | 36.65M | 68.21M |
|
|
|||||
| Total Current Liabilities | 22.98M | 21.41M | 26.12M | 36.65M | 68.21M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 11.13M | 11.88M | 12.34M | 8.23M | 8.79M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 407.72M | 421.28M | 410.74M | 397.13M | 367.68M |
| Total Liabilities | 441.83M | 454.56M | 449.20M | 442.01M | 444.68M |
|
|
|||||
| Common Stock & APIC | 689.89M | 687.18M | 560.77M | 559.28M | 179.06M |
| Retained Earnings | -692.07M | -681.82M | -657.64M | -671.47M | -614.65M |
| Treasury Stock & Other | -4.62M | -4.61M | -4.59M | -4.61M | -4.60M |
| Total Common Equity | -6.80M | 752.00K | -101.46M | -116.80M | -440.18M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | 300.55M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | 300.55M |
|
|
|||||
| Total Common Equity | -6.80M | 752.00K | -101.46M | -116.80M | -440.18M |
| Total Preferred Equity | -- | -- | -- | -- | 300.55M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -6.80M | 752.00K | -101.46M | -116.80M | -139.63M |
|
|
|||||